V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006661 | 10004502 | 1.7 | 76.3 | Adjuvant (A) | 2018-03-26 | 2018-04-02 | CARBOPLATIN + PACLITAXEL | N | N | 10450979 | CARBOPLATIN + PACLITAXEL |
| 10006662 | 10004502 | 1.6 | 58.4 | Curative (C) | 2017-07-01 | 2017-08-24 | Carboplatin + Etoposide IV 3 day | 02 | null | 10450979 | CARBOPLATIN + ETOPOSIDE |
| 10006663 | 10004503 | null | 85.7 | Adjuvant (A) | 2017-11-28 | 2018-01-06 | Bevacizumab | null | null | 10451059 | GEMCITABINE |
| 10006664 | 10007306 | 1.6 | 67.2 | Disease modification (D) | 2016-11-26 | 2016-11-27 | Azacitidine | 02 | N | 10451094 | AZACITIDINE |
| 10006665 | 10007306 | 1.72 | 93.1 | Disease modification (D) | 2016-10-17 | 2016-10-27 | BCG Intravesical | 02 | N | 10451094 | FLUOROURACIL |
| 10006666 | 10004506 | 1.64 | 66 | Disease modification (D) | 2018-03-03 | 2018-05-21 | CVP R | N | N | 10451202 | LENALIDOMIDE |
| 10006667 | 10007307 | 1.74 | 93.4 | Adjuvant (A) | 2016-12-12 | 2017-01-14 | Capecitabine | N | N | 10451202 | CAPECITABINE |
| 10006668 | 10004507 | 1.7 | 84 | Disease modification (D) | 2018-07-25 | 2018-09-25 | Lenalidomide 10mg (Cycle 1 to 25) | N | N | 10451359 | NOT MATCHED |
| 10006669 | 10004508 | 1.68 | 66.4 | null | 2014-08-13 | 2014-08-15 | Temozolomide 200mg/m2 | N | Y | 10451497 | TEMOZOLOMIDE |
| 10006670 | 10004509 | 1.7 | 67.7 | Adjuvant (A) | 2017-06-30 | 2017-07-03 | Temozolomide 150mg/m2 | 2 | N | 10451497 | TEMOZOLOMIDE |
| 10006671 | 10004510 | null | 93.1 | Palliative (P) | 2014-02-10 | 2014-02-10 | Azacitidine | N | null | 10451622 | AZACITIDINE |
| 10006672 | 10004511 | 1.8 | 82.2 | Palliative (P) | 2017-11-02 | 2017-11-22 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10451756 | GEMCARBO |
| 10006673 | 10004512 | 1.74 | 88.6 | Disease modification (D) | 2018-06-15 | 2018-06-15 | Temozolomide 200mg/m2 | 2 | null | 10451853 | TEMOZOLOMIDE |
| 10006674 | 10004512 | 1.63 | 71 | Curative (C) | 2018-12-31 | 2019-01-07 | GEMCARBO | N | N | 10451853 | NOT MATCHED |
| 10006675 | 10004515 | 1.59 | 46.5 | Curative (C) | 2014-07-23 | 2014-07-23 | Trial Unspecified | 2 | N | 10451926 | TRIAL |
| 10006676 | 10004516 | 1.57 | 61.4 | Adjuvant (A) | 2013-10-20 | 2013-10-20 | CARBOPLATIN + ETOPOSIDE | N | N | 10451926 | CARBOPLATIN + ETOPOSIDE |
| 10006677 | 10004517 | 1.8 | 120 | Adjuvant (A) | 2015-12-08 | 2015-12-10 | Carboplatin + Vinorelbine IV | N | N | 10452498 | IBRUTINIB |
| 10006678 | 10004518 | 1.47 | 69.3 | Disease modification (D) | 2014-05-11 | 2014-05-25 | Carboplatin + Pemetrexed | N | N | 10452575 | IBRUTINIB |
| 10006679 | 10004519 | 1.7 | 81.4 | Palliative (P) | 2019-01-14 | 2019-01-17 | Azacitidine | 2 | N | 10452711 | AZACITIDINE |
| 10006680 | 10004519 | null | null | null | 2014-02-13 | 2014-02-25 | CARBOPLATIN + VINORELBINE | N | N | 10452711 | CTD |
| 10006681 | 10004520 | null | 87.1 | Disease modification (D) | 2017-10-05 | 2017-10-06 | GEMCARBO | N | N | 10452876 | LENALIDOMIDE |
| 10006682 | 10004521 | 1.67 | null | Curative (C) | 2017-01-20 | 2017-01-20 | Trial Unspecified | null | Y | 10453625 | TRIAL |
| 10006683 | 10007314 | 1.71 | 0 | Palliative (P) | 2017-07-16 | 2017-07-28 | CARBOPLATIN + PACLITAXEL | N | null | 10453798 | CARBOPLATIN + PACLITAXEL |
| 10006684 | 10004522 | 1.59 | 65.6 | Palliative (P) | 2016-08-05 | 2016-08-05 | null | N | N | 10453802 | IBRUTINIB |
| 10006685 | 10004526 | 1.64 | 66.4 | Disease modification (D) | 2018-07-13 | 2018-11-01 | Lenalidomide 10mg (Cycle 1 to 25) | N | null | 10453986 | LENALIDOMIDE |
| 10006686 | 10004527 | 1.79 | null | Palliative (P) | 2014-11-27 | 2014-12-20 | Pemetrexed | 02 | null | 10453996 | IBRUTINIB |
| 10006687 | 10004529 | 1.8 | 97 | Curative (C) | 2016-05-10 | 2016-05-10 | Fluorouracil + Folinic Acid Weekly | 2 | N | 10454032 | IBRUTINIB |
| 10006688 | 10004529 | 1.52 | 56.4 | Palliative (P) | 2017-05-23 | 2017-08-13 | Trial Unspecified | N | N | 10454032 | TRIAL |
| 10006689 | 10004530 | 1.83 | 107.7 | Disease modification (D) | 2018-06-02 | 2018-06-05 | LENALIDOMIDE | 02 | N | 10454154 | CARBOPLATIN + VINORELBINE |
| 10006690 | 10004531 | 1.55 | 77.3 | Palliative (P) | 2018-01-14 | 2018-03-25 | IBRUTINIB | N | N | 10454157 | FLUOROURACIL |
| 10006691 | 10004531 | 1.62 | 65.9 | Palliative (P) | 2018-01-17 | 2018-01-27 | Azacitidine | 2 | null | 10454157 | AZACITIDINE |
| 10006692 | 10004532 | 1.75 | 73 | Curative (C) | 2018-01-20 | 2018-01-27 | BCG Intravesical | N | Y | 10454494 | BCG |
| 10006693 | 10004533 | 1.72 | 82 | Palliative (P) | 2017-01-21 | 2017-01-24 | Capecitabine | N | N | 10454495 | CAPECITABINE |
| 10006694 | 10007319 | 1.95 | 76.1 | Neo-adjuvant (N) | null | 2016-10-16 | LENALIDOMIDE | null | Y | 10454558 | FLUOROURACIL |
| 10006695 | 10004537 | 1.7 | 92.5 | Not known (9) | 2014-03-16 | 2014-03-19 | Trial Unspecified | N | N | 10454838 | TRIAL |
| 10006696 | 10008495 | null | 123 | null | 2018-06-18 | 2018-06-18 | Carboplatin + Etoposide iv&po | N | Y | 10454889 | CARBOPLATIN + ETOPOSIDE |
| 10006697 | 10004540 | 1.6 | 55.8 | Disease modification (D) | 2018-10-09 | 2018-10-10 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10454967 | GEMCITABINE |
| 10006698 | 10004540 | 1.5 | 59.1 | Neo-adjuvant (N) | 2017-12-07 | 2017-12-09 | GemCarbo Days 1+8 | 2 | N | 10454967 | CARBOPLATIN |
| 10006699 | 10004545 | 1.67 | 60.1 | Curative (C) | 2016-12-27 | 2017-01-04 | Fluorouricil + Folonic Acid (MdG) | N | N | 10455228 | NOT MATCHED |
| 10006700 | 10004546 | 0 | 64 | Palliative (P) | 2015-01-16 | 2015-01-22 | BCG Intravesical | N | N | 10455228 | CARBOPLATIN + VINORELBINE |
| 10006701 | 10004546 | 1.9 | null | Palliative (P) | 2018-08-26 | 2018-08-26 | null | N | N | 10455228 | ABIRATERONE |
| 10006702 | 10004547 | 1.54 | 79.4 | Curative (C) | 2015-12-16 | 2015-12-16 | Carboplatin AUC 6 - 10 | N | N | 10455398 | FLUOROURACIL |
| 10006703 | 10004549 | 1.8 | 79.2 | Adjuvant (A) | 2019-02-24 | 2019-02-25 | LENALIDOMIDE | N | N | 10455691 | GEMCITABINE |
| 10006704 | 10004550 | 1.75 | 67.7 | Palliative (P) | 2014-09-25 | 2014-10-10 | GEMCITABINE | 02 | N | 10455910 | PEMETREXED |
| 10006705 | 10004550 | 1.5 | 93 | Palliative (P) | 2016-04-27 | 2016-04-27 | Trial Unspecified | 2 | N | 10455910 | TRIAL |
| 10006706 | 10004551 | 1.8 | 65.2 | Adjuvant (A) | 2018-01-06 | 2018-01-13 | Abiraterone | 2 | Y | 10456007 | BEVACIZUMAB |
| 10006707 | 10004552 | 1.8 | 94.6 | Palliative (P) | 2017-04-06 | 2017-04-06 | FLUOROURACIL | N | null | 10456007 | CARBOPLATIN |
| 10006708 | 10004554 | 1.77 | 87.9 | null | 2017-04-29 | 2017-05-01 | Carboplatin AUC 6 - 10 | N | N | 10456669 | GEMCARBO |
| 10006709 | 10004555 | 1.7 | 75.2 | Palliative (P) | 2016-02-01 | 2016-02-05 | Capecitabine | 02 | N | 10456694 | CAPECITABINE |
| 10006710 | 10004556 | 1.8 | null | null | 2018-01-05 | 2018-01-19 | Carboplatin + Paclitaxel (weekly) | 2 | null | 10456717 | CARBOPLATIN + PACLITAXEL |